MedTrace Logo

Verbal Autopsy of Maternal Deaths, Stillbirths, and Neonatal Deaths in BetterBirth

NCT03213509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2019-10-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to conduct Verbal Autopsies of deaths ( stillbirths and neonatal deaths together) identified in the BetterBirth trial to identify their potential causes, timing, and social determinants.

Conditions

  • Perinatal Death
  • Neonatal Death
  • Stillbirth

Interventions

OTHER

Interview (Social and Verbal Autopsy)

Verbal autopsy is a technique used to determine the cause of death by asking caregivers, friends or family members about signs and symptoms exhibited by the deceased in the period before death. This is usually done using a standardized questionnaire that collects details on signs, symptoms, complaints and any medical history or events. The cause of death, or the sequence of causes that led to death, are assigned based on the data collected by this questionnaire and on any other available information. The social autopsy tool is used in conjunction with the verbal autopsy tool to explore the non-biological factors contributing to a death, including the social, behavioural and health systems determinants of maternal and child deaths.

Sponsors & Collaborators

  • Community Empowerment Lab

    collaborator OTHER

  • Population Services International

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Katherine Semrau, PhD · Ariadne Labs

  • Vishwajeet Kumar · Community Empowerment Lab

  • Arti Kumar · Community Empowerment Lab

  • Atul Gawande, MD, MPH · Ariadne Labs

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-03
Primary Completion
2017-08-27
Completion
2017-08-27

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03213509 on ClinicalTrials.gov